SubHero Banner
Text

March 2025

Core topics in this month’s edition include:

  • Qfitlia™ (fitusiran) – New orphan drug approval
  • Auryxia® (ferric citrate) – First-time authorized generic alternative
  • levetiracetam injection - Drug Recall

Download

Text